Crossref
Safety and effectiveness of thymoglobulin: Results of seven Japanese post marketing surveillances
Japanese Journal of Transplantation and Cellular Therapy · 2022
DOI: 10.7889/tct-20-020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Japanese Journal of Transplantation and Cellular Therapy, 2022. Verfasst von Masaaki Takatoku und 2 weiteren Autor:innen. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Takatoku, M., Kanamori, R., & Tazaki, T. (2022). Safety and effectiveness of thymoglobulin: Results of seven Japanese post marketing surveillances. Japanese Journal of Transplantation and Cellular Therapy. https://doi.org/10.7889/tct-20-020
Vancouver
Takatoku M, Kanamori R, Tazaki T. Safety and effectiveness of thymoglobulin: Results of seven Japanese post marketing surveillances. Japanese Journal of Transplantation and Cellular Therapy. 2022. doi:10.7889/tct-20-020
BibTeX
@article{Takatoku2022,
author = {Takatoku, Masaaki and Kanamori, Rie and Tazaki, Tomoko},
title = {Safety and effectiveness of thymoglobulin: Results of seven Japanese post marketing surveillances},
journal = {Japanese Journal of Transplantation and Cellular Therapy},
year = {2022},
doi = {10.7889/tct-20-020}
}
EUVIMED